Marcus Sterling is a dedicated technology commentator who specializes in artificial intelligence, digital transformation, and smart home systems. Based in the heart of Texas, he tracks how emerging software and automated hardware reshape both high-growth corporate environments and modern household dynamics, offering clear, insightful analysis of complex technical shifts for everyday readers.
Researchers provided biological expertise and feedback that helped guide the development of a new AI-powered resource released today. For the first time,...
Following 100% transfusion independence in Chinese TDT patients, new study confirms tBE is equally safe and effective for African SCD patients and...
-- Positive Phase 2 (Australia) results strengthen potential best-in-class profile of RSV+hMPV±PIV3 combination vaccines, with the potential differentiated ability to re-vaccinate individuals...
MANASSAS, Va., Sept. 5, 2026 /PRNewswire/ -- PureHealth Research is spotlighting a noticeable shift in how people approach their daily wellness routines, with...
The association's Boston Coaching Partners roster grows to three — adding an executive and career coach who helps high-performing women lead with...
MONTRÉAL, Aug. 28, 2026 /PRNewswire/ -- Pharmacy leaders, invited from around the world, gathered in Montréal today for an international forum on...
Financing supports advancement of AHB-137 toward potential commercialization, including its Phase 3 registrational program and commercialization readinessProceeds will also accelerate AHB-171 and...
SARALAND, Ala., Aug. 26, 2026 /PRNewswire/ -- As students return to school, parents are busy with supply lists, shopping for clothes, and...
- ASP2138's advancement into Phase 3 marks an important milestone in Astellas' commitment to advancing research in CLDN18.2 with its differentiated portfolio,...
TAIPEI, Aug. 23, 2026 /PRNewswire/ -- Anbogen Therapeutics Inc. (TPEx: 7784) ("Anbogen" or the "Company"), a clinical-stage precision oncology company, today announced that...
WASHINGTON, Aug. 22, 2026 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Nasdaq: VNDA) today announced that the NEREUS™ branded No. 47 entry from Rahal...
ROCKVILLE, Md. and SHANGHAI, Aug. 16, 2026 /PRNewswire/ -- AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused...
